Currently, CAL eighteen only warns about grapefruit as a result of its impact on the bioavailability of specified medicines with the selective inhibition of cytochrome P450 3A4 isoenzymes. But the product or service details (PI) For brand spanking new medicines which might be substrates for CYP3A4 m